Inverse psoriasis treated with ustekinumab

BMJ Case Rep. 2016 May 24:2016:bcr2016215019. doi: 10.1136/bcr-2016-215019.

Abstract

Inverse psoriasis is characterised by the involvement of flexural skin folds. This form of psoriasis has distinct clinical and therapeutic features. This report refers to the case of a 48-year-old Caucasian man who was observed in our department, with a clinically and biopsy proven diagnosis of inverse psoriasis. For 2 years, the patient was treated with different combinations of corticosteroids, vitamin D analogues and methotrexate, with no satisfactory response. Given the lack of a clinical response and comorbidities, latent tuberculosis was excluded, and we started treatment with ustekinumab. We chose this biological agent because the patient was a long-distance truck driver and refused the possibility of autoinjections. The patient underwent three ustekinumab injections, which resulted in significant improvement of pruritus, erythaematous lesions and quality of life.

Publication types

  • Case Reports

MeSH terms

  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / therapeutic use
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Quality of Life
  • Treatment Outcome
  • Ustekinumab / administration & dosage*
  • Ustekinumab / therapeutic use

Substances

  • Dermatologic Agents
  • Ustekinumab